Trial treatment for stomach cancer extending lives

New way of injecting drug allows double the number of patients to live beyond a year

An ongoing trial where the chemotherapy drug is injected directly into the abdominal cavity of patients with a particular type of stomach cancer has allowed more than two-thirds of them to live beyond a year.

This is double the usual number who receive conventional treatments.

Please or to continue reading the full article.

Get unlimited access to all stories at $0.99/month

  • Latest headlines and exclusive stories
  • In-depth analyses and award-winning multimedia content
  • Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*

*Terms and conditions apply.

A version of this article appeared in the print edition of The Straits Times on May 02, 2019, with the headline 'Trial treatment for stomach cancer extending lives'. Subscribe